Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics source : Www.globenewswire.com save search
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
SLNO | News | $37.53 1.02% 1.01% 190K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants therapeutics
TScan Therapeutics Announces Closing of Upsized Public Offering
Published: 2024-04-19 (Crawled : 14:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 3.04%
H: 0.0%
C: 0.0%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.13%
H: 0.0%
C: 0.0%
offering therapeutics
Preliminary Results for the Year Ended 31 December 2023
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
ATRX | News | $0.006 1724.82% 300
|
Manufacturing
| Email alert
Add to watchlist
year for results
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: 3.13%
H: 0.0%
C: 0.0%
defense
Addex to Present at the Swiss Biotech Day 2024
Published: 2024-04-19 (Crawled : 05:00) - globenewswire.com
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
|
| O: -20.4%
H: 0.0%
C: 0.0%
day biotech
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
IKT | $2.1 0.19% 52K
|
Health Technology
| Email alert
Add to watchlist
update therapeutics development
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
ANIK | $25.84 1.61% 1.59% 49K
|
Health Technology
| Email alert
Add to watchlist
first financial results
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ONCT | $8.97 4.3% 4.12% 4.5K
|
Health Technology
| Email alert
Add to watchlist
onct-534 first cancer treatment for study
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.43%
H: 4.57%
C: 0.0%
briumvi neurology sclerosis for meeting therapeutics
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
MNPR | $0.636 -6.19% -6.6% 33K
|
Health Technology
|
| O: 3.55%
H: 0.0%
C: 0.0%
nuclear presentation for meeting imaging molecular
Windtree Therapeutics Announces Reverse Stock Split
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
WINT | $0.3419 0.62% 0.61% 470K
|
Health Technology
|
| O: -30.25%
H: 0.0%
C: 0.0%
therapeutics
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CERE | $42.15 0.02% 0.02% 810K
|
Finance
|
| O: 0.78%
H: 0.0%
C: 0.0%
disease positive for topline parkinson’s trial therapeutics results living
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CMMB | $0.691 -1.29% -1.3% 15K
|
Manufacturing
|
| O: -3.38%
H: 0.0%
C: 0.0%
ccl24 disease association publication sclerosis
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
SWTX | $40.075 -5.64% -5.98% 1.4M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
first report therapeutics financial results
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.43%
H: 4.57%
C: 0.0%
cd20 briumvi contract sclerosis for therapeutics
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-04-18 (Crawled : 05:00) - globenewswire.com
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
| Email alert
Add to watchlist
year update therapeutics financial results
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
GTHX | $4.12 -1.2% -1.21% 730K
|
Health Technology
|
| O: 1.72%
H: 4.82%
C: 3.13%
first therapeutics financial results
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ALLR | $1.42 -7.79% -8.45% 460K
|
n/a
|
| O: -9.52%
H: 0.0%
C: 0.0%
nasdaq extension therapeutics
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
WINT | $0.3419 0.62% 0.61% 470K
|
Health Technology
|
| O: -4.17%
H: 0.0%
C: 0.0%
business key therapeutics financial results
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
CLDX | $37.98 -1.43% -1.45% 590K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
urticaria study
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.